Its important to use the right injection techniques and change the injection site often
Retatrutide is in Phase 3 trials for type 2 diabetes (TRANSCEND-T2D program), obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease in patients with type 2 diabetes, knee osteoarthritis, and cardiovascular outcomes [1][8][10][11]
Thats why its critical to plan with your doctor, because it really comes down to your specific situation
It is not a drug, supplement or cosmetic, it is not for human or veterinary administration, and nothing on this page should be read as guidance for any such use
Visit [ to learn more about this innovative offering and Eden's commitment to expanding access to care
population (38.4 million), with 38% of adults (97.6 million) having prediabetes